Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotech VC (Venture Capital) Funds in Ireland in December 2024

Last updated: Dec 2024 A list of 50 VC (Venture Capital) funds that invest in Biotech startups based in Ireland. We rank investors based on the number of investments they made in Biotech companies from Ireland. We update this investor list every month.

Top 50 Biotech VC (Venture Capital) Funds in Ireland in December 2024

Investor	Biotech Ireland investments
Enterprise Ireland	31
SOSV	19
Western Development Commission	12
Kernel Capital	9
Irrus Investments	7
Fountain Healthcare Partners	6
AIB Seed Capital Fund	6
Seroba Life Sciences	5
Atlantic Bridge	5
HBAN	4
HBAN Medtech Syndicate	4
European Investment Bank	4
Furthr VC	3
Atlantic Bridge University Fund	3
Boole Investment Syndicate	3
Act Venture Capital	3
The Yield Lab Europe	3
Enterprise Equity	2
Lightstone Ventures	2
Infinity Capital	2
Elkstone Capital Partners	2
Ascentifi	2
SVG Ventures	2
SVG Ventures	2
HealthCap	2
The Yield Lab	1
Kreos Capital	1
Tekla Capital Management	1
Cedas Foundation	1
Xenium Capital	1
Sandbox Industries	1
Carragh Holdings	1
Woodford Investment Management	1
Blue Wire Capital	1
Alimentos Ventures	1
Street Capital	1
Moffett Investment Holdings	1
Johnson & Johnson Innovation – JJDC	1
Carbery Group	1
Claret Capital Partners	1
Bpifrance	1
Clay Capital	1
dlab	1
EarlyBird	1
Mayo Clinic Ventures	1
ARCH Venture Partners	1
KBI Biopharma	1
Novartis Venture Fund	1
Covidien	1
Cultivian Sandbox Ventures	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Investment focus

Software, Health Care, Information Technology
Funding Round, Seed, Series A
Ireland, United States, United Kingdom

Portfolio highlights

Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
Customs Window — Customs Window is an End-to-End Customs Clearance and Trade Solutions providing Support Services to solve challenges and operations.
The Freebird Club — The social travel club for over 50s. Homestays, local events, travel advice and more.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.

Investment focus

Health Care, Medical Device, Biotechnology
Seed, Funding Round, Series A
Ireland, United States

Portfolio highlights

Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
CitySwift — CitySwift is a data-driven scheduling and planning technology for urban bus networks. It uses artificial intelligence and machine learning to predict journey times and passenger demand, making routes more efficient. Schedulers can create optimized timetables that take into account traffic, events, and hundreds of other external factors, ensuringon-time performance and increased passenger satisfaction.CitySwift was established in 2016 and is operating in Galway, Ireland.

Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
Ireland, United Kingdom, France

Portfolio highlights

Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
Causeway Sensors — The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.

Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.

Investment focus

Medical Device, Biotechnology, Health Care
Seed, Funding Round, Series A
Ireland, Sweden, United States

Portfolio highlights

Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes signiﬁcant shortness of breath and chest pain in up to 15% of patients with cancer.

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Series C
Ireland, United States, France

Portfolio highlights

MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
Mainstay Medical — Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
Ermium Therapeutics — Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.Ermium Therapeutics was founded in June 2019 by Jean-Philippe HERBEUVAL, Kurma Partners, Idinvest Partners, Domain Therapeutics and Erganeo. The company isbased in Paris and has signed a worldwide exclusive license agreement on intellectual property from CNRS and University Paris Descartes (France) through an agreement with Erganeo, which supported the maturation of the project in an academic setting. In addition, Ermium Therapeutics recently won the innovation i-Lab 2019 award from the French Ministry of Research and Higher Education.

The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of â‚¬30m under managementwith AIB and Enterprise Ireland both committing â‚¬15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately â‚¬500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of â‚¬250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed â‚¬250,000.

Investment focus

Software, Health Care, Medical
Seed, Funding Round, Series A
Ireland, United States, Jersey

Portfolio highlights

NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
Offr — Offr is the new way to buy and sell property, quickly and transparently.
Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Funding Round
Ireland, United States, United Kingdom

Portfolio highlights

Shorla Pharma — Shorla Pharma is an Irish specialty pharmaceutical company. It is growing portfolio brings accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.
Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.

Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.

Investment focus

Software, Information Technology, Artificial Intelligence
Series A, Series B, Funding Round
United States, Ireland, United Kingdom

Portfolio highlights

Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
Cambridge Mechatronics — Cambridge Mechatronics (CML) is a high technology design and engineering company based in Cambridge, UK. We specialise in pioneering and developing cutting-edge mechatronic platform technology from concept to mass production. We achieve this through technology licensing or partnerships with global manufacturing corporations. Our intellectualproperty portfolio consists of over 100 granted patents that we can exploit.

HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.

Investment focus

Health Care, Medical Device, Software
Seed, Funding Round, Series A
Ireland, United Kingdom, United States

Portfolio highlights

Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
Educatly — We help you get into the University of your dreams. We are the only platform with all the information you need to Study Abroad
Quantmatix — Improve the quality, efficiency and timing of your investment decisions. Quantmatix is a systematic tool for professional investors to evaluate instruments, dynamically shape portfolios and drive performance.

HBAN Medtech Syndicate

Investment focus

Medical Device, Medical, Health Care
Seed, Funding Round, Series B
Ireland

Portfolio highlights

FeelTect — Connected health technology for disruptive improvements to wound care
Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes signiﬁcant shortness of breath and chest pain in up to 15% of patients with cancer.

European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.

Investment focus

Biotechnology, Health Care, Energy
Debt Financing, Post-IPO Debt, Funding Round
France, Germany, The Netherlands

Portfolio highlights

BURN — The future of clean cooking
GEWOBA — GEWOBA is a real estate company that manages and provides a diverse portfolio of rental real estate apartments and properties.
Acea — Acea operates in six business segments. The water segment collects, purchases, transports and distributes drinking water, and manages the sewerage system and the purification of wastewaters. The company serves 9 million residents served in Lazio, Tuscany, Umbria, Molise and Campania; The energy segment manages the transmission and distributesroughly 9 TWh of electricity, public lighting; commercial and trading segment activities include energy management, sale of electricity and gas, energy efficiency for domestic customers. The company is targeting growth in electricity generation from renewable (photovoltaic) sources and in electric mobility, with a view to effectively contributing more and more to the energy transition and decarbonisation. The environment segment provides laboratory, research and related consultancy services on the environment and control functions within the water cycle; engineering services and overseas operations providing water services in Latin America.

Furthr VC invests in transformative tech. Furthr Venture Capital invests in scalable, early-stage companies. We help Ireland's next generation of technology.

Investment focus

Medical, Medical Device, Health Care
Seed, Funding Round, Pre-Seed
Ireland

Portfolio highlights

Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes signiﬁcant shortness of breath and chest pain in up to 15% of patients with cancer.

We invest in entrepreneurs with the ambition to create world-class companies of scale.

Investment focus

Medical Device, Health Care, Big Data
Seed, Series A, Funding Round
Ireland, United States

Portfolio highlights

CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland

Boole Investment Syndicate invests in new technology start-up's with scalability.

Investment focus

Medical Device, SaaS, EdTech
Seed, Funding Round
Ireland, United States

Portfolio highlights

Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
FeelTect — Connected health technology for disruptive improvements to wound care
SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes signiﬁcant shortness of breath and chest pain in up to 15% of patients with cancer.

Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.

Investment focus

Software, Information Technology, SaaS
Funding Round, Seed, Series A
Ireland, United States, United Kingdom

Portfolio highlights

GridBeyond — Endeco's Energy ManagementSystem (EMS) provides wirelessenergy management and controlsystems for retail, commercial andindustrial users. Applications includebuilding control, refrigeration control,demand management, priceresponse, energy efficiency, anddemand response. Our automatedwireless systems seamlesslyintegrate intoyour existingoperations and/or BuildingManagement System (BMS) withoutany training of retail staff required.
Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
Mavarick AI — Explore Mavarick AI's Carbon Accounting Software Platform. Get accurate carbon emissions accounting data and generate auditable reports with ease.

The Yield Lab Europe is a €50m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.

Investment focus

AgTech, Agriculture, Biotechnology
Seed, Series A, Funding Round
Ireland, France, United Kingdom

Portfolio highlights

Oligofeed — We developed a supplement boosting bee immunity. Our non-toxic bee-feeding product reduces bee mortality and improves the production of the hives.
Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
Micron AgriTech — Micron Agritech, driving the future of sustainable animal health. Run a FEC worm or fluke test with your phone and get results in minutes.

Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.

Investment focus

Software, Information Technology, Medical Device
Funding Round, Seed, Series B
Ireland, United States, United Kingdom

Portfolio highlights

Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Ireland, Singapore

Portfolio highlights

Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
Amber Therapeutics — Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology
Reprieve Cardiovascular — Reprieve Cardiovascular is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients.

Infinity Capital are hypothesis-driven investors - constantly calibrating ideas through a Silicon Valley/technology network that they've been building for over two decades. Their extensive technology and operating backgrounds, combined with over a dozen years each of successful startup investing, have been essential in buildingcredibility and a reputation that resonates with entrepreneurs.

Investment focus

Semiconductor, E-Commerce, Electronics
Series B, Funding Round, Series D
United States, Ireland, Canada

Portfolio highlights

AltraTech — Next Generation Molecular Detection Discover Altratech Next Generation Molecular Detection Discover Altratech At Altratech, our mission is to enable next generation molecular detection.
BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
Core Starters — Core Starters services startups and investors through blockchain-based decentralized services to solve real problems.

Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.

Investment focus

Software, Health Care, Medical
Seed, Series A, Funding Round
Ireland, United Kingdom, United States

Portfolio highlights

CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
Zerve AI — Securely Unlock Gen AI & LLMs in Your Enterprise
Retrograde — Talent agency of the future. Get early access now.

Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi

Investment focus

Medical, Health Care, Medical Device
Funding Round, Series A
Ireland

Portfolio highlights

CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.

We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.

Investment focus

AgTech, Agriculture, Farming
Pre-Seed, Seed, Funding Round
United States, Canada, Ireland

Portfolio highlights

FarmWise — FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency.
Napigen — We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration.
Iamus Technologies — Iamus Technologies Limited is an Artificial Intelligence & Robotics company based in Ireland that has developed poultry specific robotic technology that empowers poultry farmers to make better and safer production decisions. Over the last 2 years we have been working globally with poultry processors in identifying KPIs that our robots cancontinuously gather on the ground in poultry sheds and feedback instantly to both producer and the relevant personnel back at the processing plant. Results to date are impressive with automatic and accurate data recovery from the birds on every part of the floor and analysis with real-time intervention now possible. These factors are key in addressing the growing demands of modern, intensive broiler production with the Iamus robot & platform meeting these requirements.

We are a Venture & Innovation Platform Advancing the Food & Agriculture Industries We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the food and agriculture industries.

Investment focus

AgTech, Agriculture, Farming
Pre-Seed, Seed, Funding Round
United States, Canada, Ireland

Portfolio highlights

scoutlabs — We're building the world's densest digital trap network to accurately gauge insect pest pressure. This helps millions of farmers in precisely combating crop-eating insects, accelerating a transition to more sustainable methods. Good for the farmer, the environment and for our food security
Cynomys — Soluzioni IOT di monitoraggio ambientale per allevamenti e aziende
Verdi Expeditions — Verdi is building the world's first truly scalable platform for farm automation. We work with the world's largest food brands to grow better and more sustainable crops.

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Sweden, France

Portfolio highlights

Kivu Bioscience — At Kivu Bioscience, we leverage advanced, next-generation proprietary ADC technologies to deliver more precise and effective cancer treatments.
Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
SynOx Therapeutics — SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors. SynOx Therapeutics raises EUR 37m to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumors November 16, 2020. It was founded in 2020 and is located in Dublin City, Ireland.

The Yield Lab invests in AgriFood Tech companies with technologies focused on crops, animal health, digital agriculture, logistics, and food ingredients. Initial investments range from $100,000 – $1.5M.

Investment focus

Agriculture, AgTech, Biotechnology
Seed, Series A, Convertible Note
United States, Argentina, Brazil

Portfolio highlights

Seedz — Seedz - Home - Empresas
Spotta — Spotta's smart pest systems help pest control monitor and identify pests. Solutions for hospitality, care homes, agriculture, farming and forestry.
NanobOx — We use a low-voltage electric field to generate nanobubbles directly in water; significantly reducing the energy cost compared to conventional methods.

Kreos Capital is Europe's largest and leading provider of growth debt to high-growth companies with revenues up to €150 million. Since 1998, as the pioneer growth debt provider across the UK, Western Europe, Scandinavia and Israel: Kreos has completed nearly 450 transactions and committed €1.8 billion in 14 different countries. Kreos has aproven track record of adding value to portfolio companies and helping them to grow with additional capital and flexibility throughout their business cycle whilst working closely with both the portfolio company management team and their equity sponsors.The Kreos global team has extensive debt financing, management and equity investing experience, covering the pan-European market from its locations in London, Tel Aviv and Stockholm.Kreos is a value added partner, able to offer additional capital and more flexibility with lower equity dilution. Kreos's international team has extensive entrepreneurial, debt financing and equity investing experience, covering all local European markets from its locations in London, Tel Aviv and Stockholm.

Investment focus

Biotechnology, Health Care, Software
Debt Financing, Series B, Post-IPO Debt
United Kingdom, Germany, United States

Portfolio highlights

Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
BiolineRx — BioLineRx is building a best-in-class pipeline designed to deliver meaningful therapeutic benefit to patients with certain cancers and rare diseases.
Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.

We are dedicated to helping investors reach their investment goals. Get in touch with our team to explore abrdn's investment options.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series C, Series A
United States, Switzerland, France

Portfolio highlights

Oculis — Experience the Future of Eye Care: Oculis, a Clinical Biopharmaceutical Innovator, Pioneering Breakthrough Treatments for Ophthalmic Diseases & Transforming Lives Globally.
Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Endeavor BioMedicines — Endeavor BioMedicines is a clinical-stage biotechnology company developing transformational medicines for life-threatening diseases.

Cedas Foundation

Investment focus

Biotechnology, Organic, Biopharma
Seed
Ireland, United States

Portfolio highlights

Hexafly — Hexafly is a biotechnology company that develops materials and sources form insects for aquafeed, chitin, and plant nutrition industry. It offers products from the sustainable farming of insects such as insect oil, protein, frass, and chitin. The company was founded in 2016 and headquartered in Kells, Meath, Ireland.
BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.

Xenium Capital

Investment focus

Medical Device, Health Care, Biotechnology
Seed
Ireland

Portfolio highlights

Atrian Medical — AtriAN is commercializing technology created at Mayo Clinic in the US. AtriAN is an Irish Medical Device company based in Galway--A powerful and prolific hub for medical devices.AtriAN uses a gentle energy, micro Pulsed Electric Fields (mPEF) to only ablate hyperactivity. The other tissues such as the myocardium are spared.
ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland

We invest in innovation to drive lasting change in human livelinhood. We foster innovation to drive lasting change in industries that are crucial to our industry: healthcare, insurance and sustainability.

Investment focus

Health Care, Biotechnology, Agriculture
Series A, Seed, Series B
United States, India, France

Portfolio highlights

Lumeris — Tech-enabled, value-based care solutions with a proven partner that has driven measurable improvements in patient outcomes and financial success for health systems across the country.
Verituity — Transforming legacy payout systems as the only dynamic payout network that connects Banks, Payers, and Payees, with smarter, faster, and safer end-to-end verified payouts.
Indico Data — Learn how the Indico intelligent intake solution allows you to drive better outcomes with better intake.

Carragh Holdings

Investment focus

Biotechnology, Bioinformatics
Series A
Ireland

Portfolio highlights

Kastus Technologies — Kastus is embedded into glass during manufacturing. Creating the world's first surface that constantly cleans itself of over 99% of germs and viruses, including Covid 19. It works 24/7, for the lifetime of the glass.

Woodford Investment Management is a privately owned investment firm manages equity mutual funds. At Woodford, they don’t want to be just another fund management company. They want to create something different and better for their investors and they feel strongly that existing and potential clients are entitled to understand what they are doingwith their money.As investors, they are active, engaged, long-term, disciplined, diligent and focused. That’s a lot of things to say about their selves but each word is important in helping you to understand how they manage money – they will explain in more detail as they move along.Their investment approach and process are focused on value discovery, not price discovery. They believe that financial markets are inherently inefficient and that, through disciplined and diligent analysis, they can identify investment opportunities where market prices do not reflect long-term fundamental value. By exploiting this pervasive market characteristic, they believe they can create real long-term value for their investors.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United Kingdom, United States, Ireland

Portfolio highlights

Inivata — Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients.Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collectedthrough a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated.
Revolut — Join 40+ million customers globally using Revolut to send money to 160+ countries, hold up-to 36 currencies in app, spend in 150+ currencies, and manage their money.
Atom Bank — Savings accounts, a range of mortgages & business loans, you'll find it all with Atom bank. App-based and designed to be hassle-free. Download the app today.

Blue Wire Capital (BWC) supports innovation by backing visionaries who want to change how the world works, primarily at pre-seed and seed. BWC provides exceptional founders and outstanding managers with fast & flexible access to capital, assistance, and a comprehensive network.

Investment focus

Software, Advanced Materials, Art
Seed, Pre-Seed, Series A
United Kingdom, United States, France

Portfolio highlights

Faircraft — A sustainable, lab-grown alternative to animal leather.
Praktika — Automated 1-1 tutorship experience with generative AI Avatar tutors
Space DOTS — The first modular pico-labs for active in-space testing of advanced materials, from LEO to Cis-lunar and Interplanetary orbits.

Accelerate innovation in aquaculture feed and technology.

Investment focus

Farming, Aquaculture, Therapeutics
Seed
Ireland

Portfolio highlights

MicroSynbiotiX — Microsynbiotix, an Irish-based Biotechnology company making microalgal oral vaccines for aquaculture

Street Capital Financial Corporation is a Canadian wholesale lending company. As a wholesale lender, Street Capital doesnâ€™t have an expensive branch network and as such can pass those savings to the consumer. Street Capital prides itself on offering consumers competitive products and interest rates with an exceptional level of service.Havingapproved lender status with Canada Mortgage and Housing Corporation (CMHC) Street Capital is able to offer a broad spectrum of residential mortgage financing products to the consumer. Also, since weâ€™re primarily focused on the mortgage broker origination channel, youâ€™re assured that your mortgage will fit your needs comfortably.By continually working to develop innovative lending solutions and working in partnership with your local mortgage brokers, Street Capital is proud to help more Canadians realize their dreams of home ownership and enhancement.

Investment focus

Medical, Automotive, Biotechnology
Seed, Funding Round
Ireland, United States

Portfolio highlights

Biosensia — Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its componentchip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.
Drive Time Metrics — Drive Time Metrics is developing innovative new revenue streams from connected car data, and helping automotive OEMs monetize their connected vehicle platforms.

Moffett Investment Holdings is an investment firm

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B
Ireland

Portfolio highlights

Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.

JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Series C
United States, Israel, France

Portfolio highlights

TRex Bio — TRexBio is a discovery stage biotechnology company leveraging cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. Our powerful ‘deep biology’ discovery engine maps human tissue Treg behavior to disease processes, allowing us toidentify and characterize novel targets for therapeutic intervention. Leveraging this platform, we are building a broad portfolio of novel therapies that modulate the immune system to restore human tissue immune homeostasis.
G.I. Windows — G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology. This technology will allow less invasive surgery and offer the capability of developing more procedures new to the world. The company is creating a new category in healthcare designed to create less invasive surgery and reducehealthcare costs.G.I. Windows is committed to innovation that helps improve the way diagnostic and interventional procedures impact the essential balance between both patients and the healthcare system. It was founded in 2012 and is headquartered in West Bridgewater, Massachusetts, United States.
Orasis Pharmaceuticals — Discover how Orasis Pharmaceuticals is reshaping vision possibilities with innovative treatments for presbyopia.

Pioneering research and expertise in action. Through innovati drive new product innovation that creates value for our.

Investment focus

Life Science, Biotechnology, Marine Technology
Seed
Ireland

Portfolio highlights

Pure Ocean Algae — Pure Ocean Algae is a biotechnology company that integrates value chains from macro-algae and other marine resources. The company has over the winter of 2019/20 deployed its first trial lines of Palmaria palmata to sea, with initial results being extremely positive. It has also taken primary research in tank-based vegetative production andsucceeded in developing a pilot commercial plant that can produce commercial volumes of Palmaria palmata, at levels approaching 100% per week.

Claret Capital provides specialty debt financing to European growth businesses, predominantly in the technology, life sciences and environmental sectors. Typical loan sizes range from €1M-€40M with the flexibility to do larger transactions opportunistically.They look for investment opportunities in high growth business with proven managementteams in need of capital to fuel organic growth, acquisitions, equipment purchases, bridge loans and various forms of recapitalization.

Investment focus

Software, Information Technology, Mobile
Debt Financing, Funding Round, Series A
United Kingdom, Germany, United States

Portfolio highlights

Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
Holidu — Holidu is one of the fastest-growing travel tech companies worldwide that aims to finally make the search and booking of vacation rentals easy. Its search engine uses proprietary image recognition technology to compare the prices of millions of rental properties across hundred of websites including Airbnb, Booking.com, and Homeaway. This enablesusers to quickly find the ideal accommodation and to save up to 55% on their bookings. It was founded in 2014 by brothers Johannes and Michael Siebers and is headquartered in Munich, Bayern, Germany.
Exoticca — Exoticca develops an online platform intended to facilitate travel booking. The company's platform offers holiday packages which includes flights, accommodation, meals, guides and private transports, for exotic locations all around the world, enabling travelers to book travel packages online at competitive prices.

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
France, United States, Switzerland

Portfolio highlights

Dfns — Supercharge your platform with keyless custody as a service. One API to generate secure wallets, manage your crypto, sign transactions, set up business rules, monitor security, and more.
Biolevate — Accelerating Therapeutic Innovation: AI-Enhanced Workflow Automation
Orakl Oncology — Cultivated with love by the Orakl team.

VisVires New Protein is a pioneering investor focused on solving the persistent challenges of our food and feed system.

Investment focus

Food and Beverage, Biotechnology, Health Care
Series A, Series B, Funding Round
France, Israel, Germany

Portfolio highlights

MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
Infinite Roots — Mushlabs is a biotech company using fermentation to create the next generation of sustainable foods from the roots of mushrooms.
Abolis Biotechnologies — Abolis is a biotech innovator providing sustainable, tailor-made solutions for food, health, cosmetics, and chemicals industries. Embrace biotechnology for a better future.

Early-stage venture capital and resources for startups exploring new frontiers in web3, decentralization, and blockchain technology.

Investment focus

Blockchain, Software, Information Technology
Seed, Pre-Seed, Convertible Note
United States, Canada, Germany

Portfolio highlights

FleetOperate — FleetOperate is a truck driver marketplace platform that enables drivers to provide on-demand driving services to carriers and shippers. The company's platform offers booking shipment from a particular location with registered truck drivers and permits tracking of their location eliminating the problem of driver shortages, driver turnover, andunseated trucks while maintaining low costs, enabling people to transport their essentials with ease. The carriers and shippers avail Driver-as-a-Service to solve the problem of driver shortages, driver turnover, and unseated trucks while maintaining low costs.FleetOperate was founded in 2018 and is headquartered in Winnipeg, Manitoba.
Light Protocol — Light allows developers to reduce the cost of on-chain state by orders of magnitude without sacrificing the security and performance of the Solana L1.
WeatherXM — Join WeatherXM's global network powered by blockchain. Earn WXM tokens with accurate, hyperlocal forecasts for agriculture, energy, and more.

EarlyBird is a postal snacking service that delivers healthy snacks to its users’ doorstep. It provides its users with TasteBox, 5 healthy snacks and 2 unique teas, to help them through the working week. Its TasteBox also contains music and art from up and coming artists. EarlyBird was launched in 2014 and is based in London, England.

Investment focus

Mobile, Payments, Software
Series B
Germany

Portfolio highlights

finmid — Scale bigger by building your business on finmid's lending infrastructure. Our APIs enable tech companies to offer credit cards, transaction-based lending, and working capital to their business customers.
Noscendo — Noscendo operates as a diagnostics company dedicated to the identification and assessment of bloodstream-associated pathogens and other infections.
Goodlegal — Goodlegal serves as a one-stop shop for all legal requirements. It focuses on compliance, it should be able to compete with in-house lawyers, who handle an organization's internal legal matters, and law firms on both ends of the legal spectrum.

Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicatedefforts bring significant financial support to Mayo's patient care, education and research efforts.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
United States, Ireland, China

Portfolio highlights

Turtle Health — Turtle Health is a virtual fertility counselling clinic. We provide you with personalized, medically meaningful information to help you plan your fertility journey, early and affordably.
The Patient Company — The Patient Company provides clinical staff members with an automated lateral patient transfer device called SimPull. The company was founded in 2019 by Andrew Heuerman and is based in Grand Rapids, Michigan.
Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, China, United Kingdom

Portfolio highlights

Vilya — Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases.
Metsera — Metsera operates as a clinical-stage biopharmaceutical company.
Xaira Therapeutics — Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research tobetter understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.

KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & Commercial Manufacturing, and more.

Investment focus

Biotechnology, Life Science, Medical
Seed, Series A, Series D
United States, Ireland

Portfolio highlights

Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
GlycoSeLect — GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
ReForm Biologics — ReForm Biologics is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient toproduce. It was founded in 2014 and is based in Woburn, Massachusetts.

Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.
Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.

Covidien plc engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. Segments The company operates its businesses through four segments: Medical Devices includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry andmonitoring products, airway and ventilation products, vascular devices, SharpSafety products, clinical care products and other medical device products; Imaging Solutions includes the development, manufacture and marketing of radiopharmaceuticals and contrast products; Pharmaceutical Products includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients; and Medical Supplies includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products (OEM). The Medical Device segment develops, manufactures and sells an array of products which the company categorizes in the following product groups: - Endomechanical Instrumentsâ includes its laparoscopic instruments and surgical staplers. - Soft Tissue Repair Productsâ includes its sutures, mesh and biosurgery products. - Energy Devicesâ includes its vessel sealing, electrosurgical and ablation products and related capital equipment. Oximetry and Monitoring Productsâ includes its sensors, monitors and temperature management products. Airway and Ventilation Productsâ€”includes its airway, ventilator, breathing systems, sleep and inhalation therapy products. Vascular Devicesâ ”includes its compression and vascular therapy products. SharpSafety Productsâ includes its needles, syringes and sharps disposable products. Clinical Care Productsâ includes its urology, enteral feeding and other advanced woundcare products.

Investment focus

Health Care, Therapeutics, Biotechnology
Series A
Ireland

Portfolio highlights

FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

Cultivian Sandbox is a venture capital firm focused on building next-generation disruptive agriculture and food technology companies capable of generating superior returns. As early investors and active board members, we employ a hands-on approach to building companies and are often directly involved in setting company strategy, recruiting keyexecutives, and raising additional capital. Much more than simply a financial resource, we are capable of delivering tremendous value though active collaboration with our strategic partners and network, which are unparalleled in the agriculture and food industries.As both experienced operating managers and venture investors we add value to portfolio companies both through our highly skilled team and extensive industry network. Our investment team combines the domain expertise and investment experience from Cultivian Ventures and Sandbox Industries. Our expertise in sourcing, evaluating, closing, managing and ultimately exiting successful equity investments positions us not only to build stronger businesses, but reshape industries.

Investment focus

Agriculture, Biotechnology, Farming
Series A, Series B, Seed
United States, Canada, Germany

Portfolio highlights

Full Harvest — Waste less, profit more. Source imperfect and surplus fruits and vegetables up to 10-30% off.
Debut — Debut Biotech is a biotechnology company that focuses on providing specialty enzyme solutions combined with continuous manufacturing. It combines the power of enzymes with continuous manufacturing to create and modify small and large molecules for a wide range of industries and applications.The company was founded in 2019 and is based in SanDiego, California.
Leaf Agriculture — Simplify farm data integration and management with Leaf's unified agriculture API. Connect fields, operations, imagery, weather, and more from multiple providers via a single source.

Investors by industry

Artificial intelligence